4
Changes in Ownership
Climb Bio, Inc. Filed Acc 0001193125-26-291131
President and CEO sold 30,902 shares at $13.17 ($406,979)
- President and CEO acquired 68,750 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Brennan Aoife · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-27 | Exercise or conversion : show line 1 in the form 10b5-1 | +68,750 | 118,633 | D | ||
| 2026-06-29 | Sale : show line 2 in the form 10b5-1 | −30,902 | $13.17 | $406,979 | 87,731 | D |
| Open-market sales · 30,902 sh · avg $13.17 · $406,979 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-27 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Units | −68,750 | 137,500 | D |
Loading xslF345X06/ownership.xml…